n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial (Q44834841)

6 December 2017

title

n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial (English)

1 reference

6 December 2017

1 reference

chronic heart failure

1 reference

1 reference

1 reference

6 December 2017

Luigi Tavazzi

1 reference

6 December 2017

Aneta Aleksova

1 reference

6 December 2017

Serge Masson

1 reference

6 December 2017

Donata Lucci

1 reference

6 December 2017

Gianna Fabbri

1 reference

6 December 2017

Luciano Beretta

1 reference

6 December 2017

Lucio Mos

1 reference

6 December 2017

Anna Maria Paino

1 reference

6 December 2017

Gian Luigi Nicolosi

1 reference

6 December 2017

Roberto Marchioli

1 reference

6 December 2017

Gianni Tognoni

1 reference

6 December 2017

Gianfranco Sinagra

1 reference

6 December 2017

Roberto Latini

1 reference

6 December 2017

GISSI-Heart Failure Investigators

1 reference

6 December 2017

language of work or name

1 reference

9 July 2013

1 reference

European Journal of Heart Failure

6 December 2017

published in

1 reference

6 December 2017

1 reference

6 December 2017

1 reference

6 December 2017

page(s)

1289-1295

1 reference

Increasing prevalence of atrial fibrillation and flutter in the United States

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

n-3 Polyunsaturated fatty acids for the prevention of postoperative atrial fibrillation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Dietary fish intake and incident atrial fibrillation (from the Women's Health Initiative).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

Dietary factors and incident atrial fibrillation: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT103

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFT103

1 reference

6 December 2017

1 reference